Rapid dissemination refers to quickly sharing COVID-19 research findings and results with the scientific community and the public—through channels such as preprint servers, press releases, and social media—instead of waiting for the slower traditional journal-publication cycle. Alongside rapid review, it helps accelerate the collective pace of COVID-19 research. However, speed has trade-offs: faster sharing spreads potentially useful knowledge sooner, but it also raises the risk of circulating non-peer-reviewed or unsound findings that may influence clinical and public-health decisions before being adequately vetted. This node groups the evidence and artifacts that illustrate these pros and cons.